Fasting Reduces Intestinal Radiotoxicity, Enabling Dose-Escalated Radiation Therapy for Pancreatic Cancer
Marimar de la Cruz Bonilla(The University of Texas MD Anderson Cancer Center), Helen Piwnica‐Worms(Centre for Cancer Biology), Sabrina L. Jeter-Jones(The University of Texas MD Anderson Cancer Center), Kristina M. Stemler(The University of Texas MD Anderson Cancer Center), Jessica M. Molkentine(The University of Texas MD Anderson Cancer Center), Russell R. Broaddus(University of North Carolina at Chapel Hill), Cullen M. Taniguchi(The University of Texas MD Anderson Cancer Center), Xiaomei Zhang(The University of Texas MD Anderson Cancer Center), Gabriela M. Asencio Torres(The University of Texas MD Anderson Cancer Center), Tara N. Fujimoto(The University of Texas MD Anderson Cancer Center)
International Journal of Radiation Oncology*Biology*Physics
July 1, 2019
Cited by 42
Related Papers
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k
Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming
|Nature|2017|853
The Chk1 Protein Kinase and the Cdc25C Regulatory Pathways Are Targets of the Anticancer Agent UCN-01
|Journal of Biological Chemistry|2000|541
Extracellular Histones Are Mediators of Death through TLR2 and TLR4 in Mouse Fatal Liver Injury
|The Journal of Immunology|2011|522